Tufts University scientists are aiming to revolutionize the future of weight loss drugs by engineering a new compound that ...

A new study found that weight-loss medications like Ozempic and Mounjaro are not as effective in a “real-world” setting ...

Eli Lilly's experimental obesity drug, eloralintide, helped some patients lose 11.5% of their body weight at 12 weeks in an ...

As medications like Ozempic transform the health of millions of Americans, some families are discovering a surprising side ...

Gov. Josh Shapiro’s administration plans to save money by cutting poor patients’ access to expensive weight-loss drugs like ...

GLP-1 medications offer promising benefits for obesity and diabetes patients, with studies showing reduced heart attack risk ...

Here's why McDonald's is more exposed than other fast-food brands to shifts in eating habits as a result of weight-loss drugs ...

People who take weight-loss drugs hoping to achieve the impressive results observed in large clinical trials may need to ...

Options are emerging for the tens of millions of people who stop taking GLP-1 drugs because of side effects, cost or ...

Researchers found that injectable GLP-1 receptor agonists for obesity tended to yield smaller reductions in weight in ...

Real-world study shows injectable GLP-1 drugs for obesity have lower weight loss due to treatment discontinuation.